CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Open-market sale Chief Operating Officer sold 1,118 shares at $8.00 ($8,944)
- 4 Open-market sale CFO and CBO sold 1,291 shares at $8.00 ($10,328)
- 4 Open-market buy Director bought 12,500 shares at $7.93 ($99,084)
- 4 Open-market buy Director bought 10,000 shares at $8.12 ($81,248)
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market sale Chief Operating Officer sold 10,901 shares at $11.72 ($127,760)
Page 7 of 25 · 496 filings